BackApollo Endosurgery Overview

Apollo Endosurgery Receivables

Apollo Endosurgery's receivables is $15M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$14.99M
48.75% YoYΔ $4.91M vs prior year quarter

Peer trimmed avg / median

Loading

Apollo Endosurgery Receivables History

Loading

Apollo Endosurgery vs. peers: Receivables Comparison

Loading

Apollo Endosurgery Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apollo Endosurgery (APEN) FAQ

As of the most recent data (December 2022), APEN shows a receivables of $15M. That compares with $10M in the prior-year period — up 48.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APEN's receivables is now $15M (was $10M) — a 48.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apollo Endosurgery is outperforming or lagging.

Tracking APEN's receivables over time shows whether Apollo Endosurgery is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $10M in the prior-year period — up 48.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Apollo Endosurgery's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $15M) with ownership activity and broader fundamentals.

Apollo Endosurgery's receivables is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.